Cargando…

Hybrid approach for harmony transcatheter pulmonary valve replacement

The Harmony™ Transcatheter Pulmonary Valve (Medtronic) was recently approved by the Food and Drug Administration for transcatheter pulmonary valve replacement in native right ventricular outflow tracts. Despite this milestone, some patients have main pulmonary arteries that are severely dilated and...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibbani, Kamel, Aboulhosn, Jamil, Levi, Daniel, Mohammad Nijres, Bassel, Blais, Benjamin, Karimi, Mohsen, Van Arsdell, Glen, Aldoss, Osamah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099905/
https://www.ncbi.nlm.nih.gov/pubmed/36434791
http://dx.doi.org/10.1002/ccd.30504
Descripción
Sumario:The Harmony™ Transcatheter Pulmonary Valve (Medtronic) was recently approved by the Food and Drug Administration for transcatheter pulmonary valve replacement in native right ventricular outflow tracts. Despite this milestone, some patients have main pulmonary arteries that are severely dilated and continue to require surgical pulmonary valve replacement. The hybrid approach combines surgical creation of a landing zone, transcatheter valve deployment, and suture stabilization of the implanted valve. In this case series, we report the first use of a hybrid approach for Harmony™ transcatheter pulmonary valve replacement. Two cases are reported with varying approaches for surgical creation of a landing zone followed by successful placement of a Harmony™ valve.